Position in NTLA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,200,208
+$312,320 QoQ
Shares Held
93,620
-5.2% QoQ
Ownership
0.067%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTLA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026LAZARD ASSET MANAGEMENT LLC holds $361,300,548 across 55 Biotechnology names. NTLA ranks #31 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
133,347 | $97,376,646 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
213,131 | $95,171,516 | |
| 3 | INCY |
Incyte Corp
|
219,881 | $20,695,199 | |
| 4 | ONC |
BeOne Medicines Ltd.
|
62,917 | $18,684,461 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
325,851 | $18,407,322 | |
| 6 | EXEL |
Exelixis, Inc.
|
372,600 | $15,980,814 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
17,004 | $13,137,970 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
42,723 | $8,076,783 |
All Filings in NTLA
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,200,208 | 93,620 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $887,888 | 98,764 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,979,383 | 114,614 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $866,993 | 92,430 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $768,285 | 108,057 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,276,770 | 109,500 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,096,346 | 102,012 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,604,807 | 116,390 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,477,494 | 90,058 | Shares | Sole | 2024-07-09 | |
| 2023-12-31 | $3,117,083 | 102,233 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,356,461 | 106,150 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,382,992 | 107,479 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $3,967,689 | 106,458 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,657,518 | 47,507 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $4,890,679 | 87,396 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,266,317 | 82,425 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $39,895 | 549 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $47,650 | 403 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $1,341 | 10 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||